ADORA2A is thought to provide a protective effect against the development of pulmonary hypertension (85), another clinical phenotype that presents in some ROHHAD individuals consequent to recurrent low oxygen due to inadequately managed hypoventilation (5, 86). The gene discussed is ADORA2A; the disease is rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.